Joshua Jennings
Stock Analyst at TD Cowen
(2.58)
# 2,147
Out of 5,124 analysts
75
Total ratings
45.71%
Success rate
3.67%
Average return
Main Sectors:
Stocks Rated by Joshua Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OBIO Orchestra BioMed Holdings | Initiates: Buy | $15 | $4.31 | +248.03% | 1 | Dec 10, 2025 | |
| CBLL CeriBell | Maintains: Buy | $36 → $20 | $21.30 | -6.10% | 3 | Nov 5, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $25 → $15 | $5.89 | +154.67% | 2 | Nov 5, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $85 → $50 | $30.76 | +62.55% | 4 | Nov 5, 2025 | |
| DXCM DexCom | Maintains: Buy | $100 → $84 | $66.54 | +26.24% | 2 | Oct 31, 2025 | |
| HUMA Humacyte | Maintains: Buy | $5 → $3.5 | $0.98 | +258.97% | 3 | Aug 12, 2025 | |
| AVR Anteris Technologies Global | Initiates: Buy | $15 | $4.92 | +204.88% | 1 | Jan 7, 2025 | |
| PODD Insulet | Maintains: Buy | $264 → $324 | $282.92 | +14.52% | 1 | Jan 3, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $100 → $110 | $94.71 | +16.14% | 7 | Dec 12, 2024 | |
| TMDX TransMedics Group | Maintains: Buy | $175 → $120 | $122.69 | -2.19% | 9 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $1.45 | +3,348.28% | 1 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $143 → $119 | $90.02 | +32.19% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $60 | $35.61 | +68.49% | 2 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $80 | $84.27 | -5.07% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $45 | $3.70 | +1,116.22% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $100 → $70 | $85.33 | -17.97% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $185 | $207.35 | -10.78% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 | $19.50 | +105.13% | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $365 → $400 | $348.18 | +14.88% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $60 | $68.84 | -12.84% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $34 | $21.55 | +57.77% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $18 | $7.80 | +130.77% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $25 | $18.42 | +35.72% | 1 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $130 | $124.19 | +4.68% | 9 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $5 | $2.32 | +115.52% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $117 | $96.05 | +21.81% | 3 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $450 | $2.52 | +17,757.14% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $12 | $20.76 | -42.20% | 1 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $306 → $275 | $194.94 | +41.07% | 1 | Feb 7, 2020 |
Orchestra BioMed Holdings
Dec 10, 2025
Initiates: Buy
Price Target: $15
Current: $4.31
Upside: +248.03%
CeriBell
Nov 5, 2025
Maintains: Buy
Price Target: $36 → $20
Current: $21.30
Upside: -6.10%
Senseonics Holdings
Nov 5, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $5.89
Upside: +154.67%
PROCEPT BioRobotics
Nov 5, 2025
Maintains: Buy
Price Target: $85 → $50
Current: $30.76
Upside: +62.55%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $100 → $84
Current: $66.54
Upside: +26.24%
Humacyte
Aug 12, 2025
Maintains: Buy
Price Target: $5 → $3.5
Current: $0.98
Upside: +258.97%
Anteris Technologies Global
Jan 7, 2025
Initiates: Buy
Price Target: $15
Current: $4.92
Upside: +204.88%
Insulet
Jan 3, 2025
Maintains: Buy
Price Target: $264 → $324
Current: $282.92
Upside: +14.52%
Boston Scientific
Dec 12, 2024
Maintains: Buy
Price Target: $100 → $110
Current: $94.71
Upside: +16.14%
TransMedics Group
Nov 18, 2024
Maintains: Buy
Price Target: $175 → $120
Current: $122.69
Upside: -2.19%
Oct 2, 2024
Initiates: Buy
Price Target: $50
Current: $1.45
Upside: +3,348.28%
Sep 6, 2024
Maintains: Hold
Price Target: $143 → $119
Current: $90.02
Upside: +32.19%
Aug 27, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $35.61
Upside: +68.49%
Aug 13, 2024
Maintains: Hold
Price Target: $83 → $80
Current: $84.27
Upside: -5.07%
Aug 8, 2024
Maintains: Buy
Price Target: $135 → $45
Current: $3.70
Upside: +1,116.22%
Jul 25, 2024
Downgrades: Hold
Price Target: $100 → $70
Current: $85.33
Upside: -17.97%
Jul 18, 2024
Maintains: Buy
Price Target: $195 → $185
Current: $207.35
Upside: -10.78%
May 10, 2024
Downgrades: Hold
Price Target: $40
Current: $19.50
Upside: +105.13%
Apr 11, 2024
Maintains: Buy
Price Target: $365 → $400
Current: $348.18
Upside: +14.88%
Mar 12, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $68.84
Upside: -12.84%
Aug 4, 2023
Maintains: Outperform
Price Target: $52 → $34
Current: $21.55
Upside: +57.77%
May 11, 2023
Maintains: Outperform
Price Target: $14 → $18
Current: $7.80
Upside: +130.77%
Dec 30, 2022
Maintains: Outperform
Price Target: $6 → $25
Current: $18.42
Upside: +35.72%
Dec 13, 2022
Maintains: Outperform
Price Target: $130
Current: $124.19
Upside: +4.68%
Nov 11, 2022
Maintains: Outperform
Price Target: $7 → $5
Current: $2.32
Upside: +115.52%
May 27, 2022
Maintains: Outperform
Price Target: $125 → $117
Current: $96.05
Upside: +21.81%
Dec 7, 2021
Initiates: Outperform
Price Target: $450
Current: $2.52
Upside: +17,757.14%
Sep 3, 2020
Initiates: Outperform
Price Target: $12
Current: $20.76
Upside: -42.20%
Feb 7, 2020
Downgrades: Market Perform
Price Target: $306 → $275
Current: $194.94
Upside: +41.07%